We are live on ! Find out more
RCKT icon

Rocket Pharmaceuticals
RCKT

15 hedge funds and large institutions have $52.5M invested in Rocket Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 15 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
15
Holders Change
+15
Holders Change %
–
% of All Funds
0.4%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
15
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
DPA
Devon Park Associates
+$19M
2
RCP
Rho Capital Partners
New York
+$16.8M
3
Jennison Associates
Jennison Associates
New York
+$5.87M
4
Franklin Resources
Franklin Resources
California
+$4.89M
5
PCM
Pentwater Capital Management
Florida
+$4.11M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
DPA
1
Devon Park Associates
$17.6M +$19M +810,927 New
RCP
2
Rho Capital Partners
New York
$15.6M +$16.8M +717,646 New
Jennison Associates
3
Jennison Associates
New York
$5.42M +$5.87M +250,230 New
Franklin Resources
4
Franklin Resources
California
$4.51M +$4.89M +208,250 New
PCM
5
Pentwater Capital Management
Florida
$3.79M +$4.11M +175,000 New
SFM
6
Sphera Funds Management
Israel
$2.17M +$2.35M +100,000 New
TI
7
Telemetry Investments
New York
$1.13M +$1.22M +51,891 New
AllianceBernstein
8
AllianceBernstein
Tennessee
$1.11M +$1.2M +50,995 New
SIM
9
Spark Investment Management
New York
$533K +$587K +25,025 New
PVI
10
Pura Vida Investments
New York
$474K +$513K +21,875 New
Morgan Stanley
11
Morgan Stanley
New York
$97K +$106K +4,515 New
Northern Trust
12
Northern Trust
Illinois
$90K +$97.8K +4,165 New
Citigroup
13
Citigroup
New York
$21K +$22.3K +950 New
BIM
14
BlackRock Investment Management
Delaware
$6K +$6.64K +283 New
UBS Group
15
UBS Group
Switzerland
$5K +$5.56K +237 New

RCKT Hedge Fund Activity: Q1 2015 in Review

15 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Rocket Pharmaceuticals (RCKT) for Q1 2015, worth a combined $52.5M.

Buyers outnumbered sellers: 15 funds opened new RCKT positions and 0 closed out — a net gain of 15 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Devon Park Associates, opening a new position worth an estimated $19M.

  • 15 institutional investors held Rocket Pharmaceuticals (RCKT) as of Q1 2015, up from 0 in Q4 2014.
  • Funds reported $52.5M of Rocket Pharmaceuticals stock for Q1 2015.
  • 15 funds opened new Rocket Pharmaceuticals positions in Q1 2015 and 0 closed out, a net change of +15 holders.
  • The largest Rocket Pharmaceuticals buyer in Q1 2015 was Devon Park Associates, an estimated $19M added.

Based on aggregated 13F filings for Q1 2015.